Koung Jin Suh

2.3k total citations
98 papers, 1.2k citations indexed

About

Koung Jin Suh is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Cancer Research. According to data from OpenAlex, Koung Jin Suh has authored 98 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 62 papers in Oncology, 35 papers in Pulmonary and Respiratory Medicine and 17 papers in Cancer Research. Recurrent topics in Koung Jin Suh's work include Cancer Immunotherapy and Biomarkers (20 papers), Lung Cancer Treatments and Mutations (11 papers) and Advanced Breast Cancer Therapies (10 papers). Koung Jin Suh is often cited by papers focused on Cancer Immunotherapy and Biomarkers (20 papers), Lung Cancer Treatments and Mutations (11 papers) and Advanced Breast Cancer Therapies (10 papers). Koung Jin Suh collaborates with scholars based in South Korea, United States and Japan. Koung Jin Suh's co-authors include Yu Jung Kim, Se Hyun Kim, Jee Hyun Kim, Bhumsuk Keam, Tae Min Kim, Dae Seog Heo, Seock‐Ah Im, Jong Seok Lee, Dong‐Wan Kim and Ji‐Won Kim and has published in prestigious journals such as JAMA, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Koung Jin Suh

92 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Koung Jin Suh South Korea 18 786 475 271 215 178 98 1.2k
Véronique D’Hondt France 21 781 1.0× 335 0.7× 298 1.1× 241 1.1× 144 0.8× 83 1.3k
Édith Borcoman France 17 948 1.2× 419 0.9× 239 0.9× 170 0.8× 150 0.8× 50 1.3k
Sung Hoon Sim South Korea 18 493 0.6× 325 0.7× 243 0.9× 230 1.1× 131 0.7× 81 1.0k
Roberto Carmagnani Pestana United States 17 547 0.7× 279 0.6× 217 0.8× 192 0.9× 133 0.7× 52 1.1k
Aránzazu Manzano Spain 16 571 0.7× 308 0.6× 240 0.9× 200 0.9× 216 1.2× 58 1.1k
Pallavi S. Mishra‐Kalyani United States 22 883 1.1× 560 1.2× 332 1.2× 191 0.9× 167 0.9× 49 1.5k
Andrew Dean Australia 17 1.1k 1.4× 694 1.5× 262 1.0× 267 1.2× 198 1.1× 104 1.6k
Youling Gong China 21 534 0.7× 662 1.4× 439 1.6× 178 0.8× 256 1.4× 89 1.4k
Federica Cuppone Italy 20 1.1k 1.4× 604 1.3× 199 0.7× 388 1.8× 111 0.6× 50 1.5k
Miso Kim South Korea 25 1.2k 1.5× 710 1.5× 292 1.1× 208 1.0× 248 1.4× 87 1.7k

Countries citing papers authored by Koung Jin Suh

Since Specialization
Citations

This map shows the geographic impact of Koung Jin Suh's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Koung Jin Suh with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Koung Jin Suh more than expected).

Fields of papers citing papers by Koung Jin Suh

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Koung Jin Suh. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Koung Jin Suh. The network helps show where Koung Jin Suh may publish in the future.

Co-authorship network of co-authors of Koung Jin Suh

This figure shows the co-authorship network connecting the top 25 collaborators of Koung Jin Suh. A scholar is included among the top collaborators of Koung Jin Suh based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Koung Jin Suh. Koung Jin Suh is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kim, Se Hyun, Sejoon Lee, Min-Su Kang, et al.. (2024). Association of TP53 Mutation Status and Sex with Clinical Outcome in Non–Small Cell Lung Cancer Treated with Immune Checkpoint Inhibitors: A Retrospective Cohort Study. Cancer Research and Treatment. 57(1). 70–82. 1 indexed citations
2.
Jung, Eun Hee, Yusuke Hiratsuka, Sang‐Yeon Suh, et al.. (2024). Clinicians’ Prediction of Survival Is Most Useful for Palliative Care Referral. SHILAP Revista de lepidopterología. 5(1). 365–372.
3.
Lee, Ji Yun, Ju Hyun Lee, Min-Su Kang, et al.. (2024). Skeletal-Related Events in Patients With Multiple Myeloma: A Comprehensive Retrospective Cohort Study. Journal of Korean Medical Science. 39(22). e175–e175. 1 indexed citations
4.
Kim, Eun‐Kyu, Eunyoung Kang, Jee Hyun Kim, et al.. (2023). Development and External Validation of a Machine Learning Model to Predict Pathological Complete Response After Neoadjuvant Chemotherapy in Breast Cancer. Journal of Breast Cancer. 26(4). 353–353. 3 indexed citations
5.
Woo, Ji Won, et al.. (2023). PD-L1 (SP142) Expression in Primary and Recurrent/Metastatic Triple-Negative Breast Cancers and Its Clinicopathological Significance. Cancer Research and Treatment. 56(2). 557–566. 2 indexed citations
6.
Lee, Y. S., Ho Kang, Koung Jin Suh, et al.. (2023). Primary Intracranial Ewing Sarcoma With EWSR1-FLI1 Gene Translocation Mimicking a Meningioma and a Multidisciplinary Therapeutic Approach: A Case Report and Systematic Review of Literatures. Brain Tumor Research and Treatment. 11(4). 281–281. 3 indexed citations
7.
Suh, Koung Jin, Min‐Hee Ryu, Dae Young Zang, et al.. (2023). AZD8186 in Combination With Paclitaxel in Patients With Advanced Gastric Cancer: Results From a Phase Ib/II Study (KCSG ST18-20). The Oncologist. 28(9). e823–e834. 12 indexed citations
8.
Jung, Eun Hee, Yu Jung Kim, Beodeul Kang, et al.. (2022). Clinical Outcomes of Operating an Acute Palliative Care Unit at a Comprehensive Cancer Center. JCO Oncology Practice. 18(10). e1661–e1671. 8 indexed citations
9.
Kim, Se Hyun, Eun Hee Jung, Koung Jin Suh, et al.. (2022). The effect of metformin or dipeptidyl peptidase 4 inhibitors on clinical outcomes in metastatic non‐small cell lung cancer treated with immune checkpoint inhibitors. Thoracic Cancer. 14(1). 52–60. 13 indexed citations
10.
Kim, Yu Jung, Sang‐Yeon Suh, Yusuke Hiratsuka, et al.. (2022). Performance of clinician prediction of survival in oncology outpatients with advanced cancer. PLoS ONE. 17(4). e0267467–e0267467. 7 indexed citations
11.
Lee, Ji Yun, Min-Su Kang, Koung Jin Suh, et al.. (2020). Pneumocystis jirovecii pneumonia in diffuse large B‐cell Lymphoma treated with R‐CHOP. Mycoses. 64(1). 60–65. 8 indexed citations
12.
Kim, Kui‐Jin, Ji‐Won Kim, Koung Jin Suh, et al.. (2020). PI3K-targeting strategy using alpelisib to enhance the antitumor effect of paclitaxel in human gastric cancer. Scientific Reports. 10(1). 12308–12308. 25 indexed citations
13.
Kim, Se Hyun, Soomin Ahn, Koung Jin Suh, et al.. (2020). Identifying germline APOBEC3B deletion and immune phenotype in Korean patients with operable breast cancer. Breast Cancer Research and Treatment. 183(3). 697–704. 2 indexed citations
14.
Yang, Yaewon, Ahrum Min, Kyung-Hun Lee, et al.. (2020). Prognostic Role of Androgen Receptor Expression in Surgically Resected Early Breast Cancer Patients. Journal of Breast Cancer. 23(2). 182–182. 9 indexed citations
15.
Kwon, Jihyun, Kui‐Jin Kim, Koung Jin Suh, et al.. (2019). Afatinib Overcomes Pemetrexed-Acquired Resistance in Non-Small Cell Lung Cancer Cells Harboring an EML4-ALK Rearrangement. Cells. 8(12). 1538–1538. 9 indexed citations
16.
Han, Jae Joon, Jin Won Kim, Koung Jin Suh, et al.. (2019). Clinical characteristics and outcomes of patients enrolled in clinical trials compared with those of patients outside clinical trials in advanced gastric cancer. Asia-Pacific Journal of Clinical Oncology. 15(3). 158–165. 4 indexed citations
17.
Min, Ahrum, Hyemin Jang, Seongyeong Kim, et al.. (2018). Androgen Receptor Inhibitor Enhances the Antitumor Effect of PARP Inhibitor in Breast Cancer Cells by Modulating DNA Damage Response. Molecular Cancer Therapeutics. 17(12). 2507–2518. 15 indexed citations
18.
Choi, In Sil, Jee Hyun Kim, Ju Hyun Lee, et al.. (2018). A population-based outcomes study of patients with metastatic gastric cancer receiving second-line chemotherapy: A nationwide health insurance database study. PLoS ONE. 13(10). e0205853–e0205853. 8 indexed citations
19.
Kim, Se Hyun, Chan-Young Ock, Koung Jin Suh, et al.. (2018). BGJ398, A Pan-FGFR Inhibitor, Overcomes Paclitaxel Resistance in Urothelial Carcinoma with FGFR1 Overexpression. International Journal of Molecular Sciences. 19(10). 3164–3164. 17 indexed citations
20.
Beom, Seung‐Hoon, Jisu Oh, Tae‐Yong Kim, et al.. (2016). Efficacy of Letrozole as First-Line Treatment of Postmenopausal Women with Hormone Receptor–Positive Metastatic Breast Cancer in Korea. Cancer Research and Treatment. 49(2). 454–463. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026